Trial intelligence / Profile preview

Rat nerve growth factor injection in children with spinal muscular atrophy

ChiCTR-TRC-10001093Phase 4Completed

Sponsor
Chinese PLA General Hospital
Start
Sep 2010
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised, open-label trial of rat nerve growth factor in spinal muscular atrophy (SMA) (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Pediatric Evaluation of Disability Inventory (PEDI). Started Sep 2010; status: completed.

02

Drugs

rat nerve growth factor
03

Conditions

spinal muscular atrophy (SMA)

Beyond the preview

Go deeper on ChiCTR-TRC-10001093.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-10001093.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call